Effects of prenatal opioid exposure on mothers and their children
Prenatal Opioid Exposure: Birth, health, socioeconomic, and educational outcomes of mothers and their children
This study looks at how being exposed to opioids during pregnancy affects mothers and their children in the long run, using data from nearly 800,000 births in Wisconsin to better understand their health, education, and overall well-being.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Wisconsin-Madison NIH-funded |
| Lab location | 1 site (Madison, United States) |
| Project ID | NIH-10834094 on NIH RePORTER |
What this research studies
This research investigates the outcomes of mothers and their children who have been exposed to opioids during pregnancy. By analyzing a large dataset of nearly 800,000 live births in Wisconsin, the study aims to understand the long-term effects of prenatal opioid exposure on health, socioeconomic status, and educational achievements. The research employs advanced statistical methods to track and analyze the data over time, focusing on both individual and community factors that may influence these outcomes. This comprehensive approach seeks to fill gaps in knowledge regarding the impact of the opioid epidemic on families.
Who could benefit from this research
Good fit: Ideal candidates for this research include mothers who have used opioids during pregnancy and their children, particularly those born between 2007 and 2018 in Wisconsin.
Not a fit: Patients who have not been exposed to opioids during pregnancy or those outside the specified geographic area may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and interventions for families affected by prenatal opioid exposure.
How similar studies have performed: Previous research has indicated significant impacts of prenatal substance exposure on child development, suggesting that this study's approach could yield valuable insights.
Where this research is happening
Madison, United States
- University of Wisconsin-Madison — Madison, United States (Active)
Researchers
- Principal investigator: Berger, Lawrence M — University of Wisconsin-Madison
- Study coordinator: Berger, Lawrence M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.